A polysaccharide antigen-antibody complex dissociating agent and its application
By using an acidic dissociation solution with a pH of -1.0 to 3.0 under acidic conditions, the dissociation of polysaccharide antigen-antibody complexes in the prior art was solved by using an acidic dissociation solution with a pH of -1.0 to 3.0, and combining with a neutralizing solution to adjust the pH. The problem of low efficiency has achieved efficient and accurate detection of polysaccharide antigens.
Patent Information
- Application Number
- CN202110181157.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2021-02-09
- Publication Date
- 2024-11-19
- Estimated Expiration
- 2041-02-09
AI Technical Summary
The prior art is difficult to effectively dissociate polysaccharide antigen-antibody complexes, resulting in low detection sensitivity and cumbersome operation, especially inapplicable for polysaccharide antigen-antibody complexes. The existing methods are harsh under temperature and solution conditions. , affects detection efficiency and accuracy.
Acid dissociation solution with a pH of -1.0 to 3.0, including amino acids and strong acids, is used to treat polysaccharide antigen-antibody complexes. The antibodies are inactivated under acidic conditions and the polysaccharide antigens maintain biological activity, and then pass through the neutralization solution. Adjust the pH to 5.0-9.0 to achieve immunologic detection of polysaccharide antigens.
It realizes rapid and effective dissociation of polysaccharide antigen-antibody complexes, simplifies the operation process, significantly shortens the processing time, improves the accuracy and sensitivity of the detection results, and is suitable for the detection of a variety of polysaccharide antigens.
Smart Images

Figure BDA0002941490990000071 
Figure BDA0002941490990000081 
Figure BDA0002941490990000082
Abstract
Description
Technical Field
[0001] The invention belongs to the field of biotechnology and relates to a polysaccharide antigen-antibody complex dissociating agent and application thereof. Background Art
[0002] After polysaccharide antigens enter the body, they combine with the host's immune antibodies to form antigen-antibody complexes. The immune antibodies occupy the antigen epitopes, limiting the sensitivity of immunological methods to detect polysaccharide antigens. Existing methods usually use EDTA-2Na to heat treat blood samples, dissociate polysaccharide antigen-antibody complexes, and then perform immunological testing. Taking BioRad's Aspergillus galactomannan detection product as an example, the sample is first mixed with EDTA-2Na solution in a ratio of 3:1, then heated at 100-120°C for 3-6 minutes, centrifuged at 4°C for 10-15 minutes, and the supernatant is aspirated for immunological testing. This operation requires processing samples at different temperatures, which is cumbersome and highly dependent on equipment, increasing operating costs and reducing detection efficiency.
[0003] CN1811444A discloses a piezoelectric mass immunosensor for Schistosoma japonicum, which uses a direct antigen fixation method to covalently bind Schistosoma japonicum dominant diagnostic antigen molecules 31 / 32 kDa to the surface of a quartz crystal. The used quartz crystal is soaked in tetrahydrofuran (THF), which can dissociate the antigen-antibody complex and wash it off the sensing surface without damaging the activity of the solid-phase antigen. However, THF is not suitable for dissociating polysaccharide antigen-antibody complexes.
[0004] CN101832999A discloses an antigen-antibody complex dissociation solution kit and its application, which is prepared by mixing equal amounts of reagents with a volume percentage concentration of 0.3% Triton-X100, 1.5% sodium dodecyl sulfate and 1.5% 3-[(3-cholanamide propyl)-dimethylammonium] propanesulfonic acid. The kit effectively realizes the rapid dissociation of pathogenic antigen-antibody complexes in serum or plasma samples to be tested, improves the absolute concentration values of antigens and antibodies, and greatly improves the detection sensitivity of samples to be tested. However, the dissociation solution needs to treat the sample at 56°C for 30 minutes, the treatment temperature is strictly harsh, and it is not suitable for the dissociation of polysaccharide antigen-antibody complexes.
[0005] Therefore, it is necessary to prepare an efficient dissociation solution for the polysaccharide antigen-antibody complex to improve the dissociation efficiency without destroying the polysaccharide antigen. Summary of the invention
[0006] In view of the deficiencies of the prior art and actual needs, the present invention provides a polysaccharide antigen-antibody complex dissociation agent and its application. The polysaccharide antigen-antibody complex is treated with a strong acid solution. Under acidic conditions, the antibody is inactivated, while the polysaccharide antigen still maintains stable biological activity, thereby achieving the effect of simple and efficient dissociation of the polysaccharide antigen-antibody complex.
[0007] To achieve this object, the present invention adopts the following technical solutions:
[0008] In a first aspect, the present invention provides a polysaccharide antigen-antibody complex dissociating agent, the polysaccharide antigen-antibody complex dissociating agent comprises an acidic dissociating solution, and the acidic dissociating solution comprises amino acids and a strong acid;
[0009] The pH of the acidic dissociation solution is -1.0 to 3.0, for example, -1.0, 0, 1.0, 2.0 or 3.0, preferably 0.
[0010] In the present invention, an acidic dissociation solution with a pH of -1.0 to 3.0 is used to treat the polysaccharide antigen-antibody complex. The polysaccharide antigen-antibody complex rapidly dissociates under acidic conditions, and protein interfering substances in the sample (such as specific antibodies for polysaccharide antigens) are rapidly inactivated, while the polysaccharide antigens have high acid stability and still maintain biological activity. After the pH is subsequently adjusted to 5.0 to 9.0 with a neutralizing solution, immunological detection of the polysaccharide antigen can be further performed.
[0011] In the present invention, an acidic dissociation solution with a pH of -1.0 to 3.0 is used to treat the polysaccharide antigen-antibody complex. Since the acid resistance of polysaccharides is much higher than that of proteins, the acidic dissociation solution not only enhances the dissociation effect and increases the release rate of polysaccharide antigens, but also can irreversibly inactivate the specific antibodies of the polysaccharide antigens, thereby avoiding interference with subsequent immunological detection. Although a dissociation solution with a pH greater than 3.0 can also achieve the dissociation of the polysaccharide antigen-antibody complex, it will cause the dissociated specific antibodies to remain active, thereby interfering with subsequent immunological detection, reducing the accuracy of the detection results, and even causing false negatives.
[0012] Preferably, the amino acids include any one or a combination of at least two of glycine, alanine, tryptophan, threonine, serine, lysine, glutamic acid, histidine or leucine, preferably glycine and / or alanine, and more preferably glycine.
[0013] Preferably, the strong acid includes any one of hydrochloric acid, nitric acid or sulfuric acid or a combination of at least two thereof, preferably hydrochloric acid.
[0014] Preferably, the concentration of the amino acid in the acidic dissociation solution is 0.1-2M, for example, 0.1M, 0.2M, 0.3M, 0.4M, 0.5M, 0.6M, 0.7M, 0.8M, 0.9M, 1M, 1.1M, 1.2M, 1.3M, 1.4M, 1.5M, 1.6M, 1.7M, 1.8M, 1.9M or 2M.
[0015] Preferably, the concentration of the strong acid in the acidic dissociation solution is 0.1-5M, for example, 0.1M, 0.5M, 1M, 1.5M, 2M, 2.5M, 3M, 3.5M, 4M, 4.5M or 5M.
[0016] In the present invention, 0.1-2M amino acid-strong acid solution, preferably 0.1-2M glycine and 0.1-5M hydrochloric acid, or 0.1-2M alanine and 0.1-5M nitric acid, further preferably 0.1M glycine and 1M hydrochloric acid solution is used as the acidic dissociation solution, which has a good dissociation effect, not only inactivating protein interferents but also ensuring that polysaccharide antigens are still active. The treated samples are used for the detection of polysaccharide antigens, and the detection results are highly accurate.
[0017] Preferably, the polysaccharide antigen-antibody complex dissociating agent further comprises a neutralizing solution for adjusting the sample containing the polysaccharide antigen-antibody complex to a neutral pH.
[0018] Preferably, the pH of the neutralization solution is 7.0 to 15.0, for example, it may be 7.0, 8.0, 9.0, 10.0, 11.0, 12.0, 13.0, 14.0 or 15.0, preferably 12.0 to 15.0.
[0019] In the present invention, a neutralizing solution with a pH of 7.0 to 15.0 is used to adjust the pH of the sample, which can quickly neutralize the acidic dissociation solution and make the sample pH reach 5.0 to 9.0, which is beneficial for subsequent immunodetection of polysaccharide antigens.
[0020] Preferably, the neutralizing solution is an alkaline or neutral to alkaline solution, including any one or a combination of at least two of tripotassium phosphate solution, trisodium phosphate solution, dipotassium hydrogen phosphate solution, disodium hydrogen phosphate solution, potassium carbonate solution, sodium carbonate solution, potassium bicarbonate solution, sodium bicarbonate solution or Tris base solution, phosphate buffer, carbonate buffer or Tris-HCl buffer.
[0021] Preferably, the neutralizing liquid is a tripotassium phosphate solution. Tripotassium phosphate is a strong base and weak acid salt with strong alkalinity and buffering capacity, and can prevent strong alkalinity or strong acidity caused by excess or deficiency. The concentration of the tripotassium phosphate solution is 0.1 to 5M, for example, it can be 0.1M, 0.5M, 1M, 1.5M, 2M, 2.5M, 3M, 3.5M, 4M, 4.5M or 5M, preferably 1.5M.
[0022] In a second aspect, the present invention provides a method for dissociating a polysaccharide antigen-antibody complex, wherein the method uses the polysaccharide antigen-antibody complex dissociating agent described in the first aspect to treat a sample.
[0023] Preferably, the method comprises the following steps:
[0024] (1) adding an acidic dissociation solution to a sample containing polysaccharide antigen-antibody complexes and incubating for dissociation;
[0025] (2) A neutralizing solution is added to the dissociated sample to adjust the pH of the sample containing the polysaccharide antigen-antibody complex to a neutral pH.
[0026] Preferably, the sample in step (1) comprises a blood sample.
[0027] Preferably, the volume ratio of the acidic dissociation solution to the sample in step (1) is 1:(0.2-10), for example, it can be 1:0.2, 1:1, 1:2, 1:3, 1:4, 1:5, 1:6, 1:7, 1:8, 1:9 or 1:10, preferably 1:3.
[0028] Preferably, the incubation temperature for dissociation in step (1) is 2 to 40°C, for example, it can be 2°C, 5°C, 8°C, 10°C, 12°C, 15°C, 18°C, 20°C, 22°C, 25°C, 28°C, 30°C, 32°C, 35°C, 38°C or 40°C, preferably 37°C.
[0029] Preferably, the incubation and dissociation time in step (1) is 2 to 20 min, for example, it can be 2 min, 3 min, 4 min, 5 min, 6 min, 7 min, 8 min, 9 min, 10 min, 11 min, 12 min, 13 min, 14 min, 15 min, 16 min, 17 min, 18 min, 19 min or 20 min, preferably 2 min.
[0030] In the present invention, the acidic dissociation solution and the sample are mixed in a volume ratio of 1:(0.2-10) and incubated at 2-40°C for 2-20 minutes, thereby achieving an efficient dissociation effect. Compared with the existing dissociation method, the operation is simple, the conditions are controllable, and the dissociation time is significantly shortened.
[0031] Preferably, the volume ratio of the neutralization solution to the sample in step (2) is 1:(0.2-10), for example, it can be 1:0.2, 1:1, 1:2, 1:3, 1:4, 1:5, 1:6, 1:7, 1:8, 1:9 or 1:10, preferably 1:4.
[0032] Preferably, after adding the neutralizing solution in step (2), a further step of mixing is included, preferably vortex mixing, so that the neutralizing solution and the sample are mixed efficiently and quickly.
[0033] Preferably, the rotation speed of the vortex mixing is 50 to 400 rpm, for example, it can be 50 rpm, 100 rpm, 150 rpm, 200 rpm, 250 rpm, 300 rpm, 350 rpm or 400 rpm, preferably 200 rpm.
[0034] Preferably, the vortex mixing time is 5 to 600 s, for example, it can be 5 s, 50 s, 100 s, 150 s, 200 s, 250 s, 300 s, 350 s, 400 s, 450 s, 500 s, 550 s or 600 s, preferably 120 s.
[0035] In the present invention, the neutralizing solution and the sample are mixed in a volume ratio of 1:(0.2-10), and vortexed at 50-400 rpm for 5-600 s, thereby achieving the effect of rapidly neutralizing the acidic dissociation solution.
[0036] As a preferred technical solution, the polysaccharide antigen-antibody complex dissociation method comprises the following steps:
[0037] (1) adding an acidic dissociation solution to a blood sample containing a polysaccharide antigen-antibody complex, wherein the volume ratio of the acidic dissociation solution to the sample is 1:(0.2-10), and incubating at 2-40° C. for 2-20 minutes to perform incubation dissociation;
[0038] (2) Adding a neutralizing solution to the dissociated sample, wherein the volume ratio of the neutralizing solution to the sample is 1:(0.2-10), vortex mixing at 50-400 rpm for 5-600 s, and adjusting the sample containing the polysaccharide antigen-antibody complex to a neutral pH.
[0039] In a third aspect, the present invention provides use of the polysaccharide antigen-antibody complex dissociation agent described in the first aspect in the preparation of a polysaccharide antigen detection kit.
[0040] Preferably, the polysaccharide antigen comprises any one of Aspergillus galactomannan, Candida mannan, Cryptococcal capsular polysaccharide or fungal 1,3-β-D glucan or a combination of at least two thereof.
[0041] In a fourth aspect, the present invention provides a fungal polysaccharide detection kit, the kit comprising the polysaccharide antigen-antibody complex dissociating agent described in the first aspect.
[0042] Preferably, the kit further comprises polysaccharide antigen-specific detection antibodies.
[0043] Compared with the prior art, the present invention has the following beneficial effects:
[0044] (1) The present invention uses an acidic dissociation solution with a pH of -1.0 to 3.0 to treat a sample containing a polysaccharide antigen-antibody complex at 2 to 40°C. The antigen-antibody complex rapidly dissociates, and the antibody is inactivated under acidic conditions, while the polysaccharide antigen still retains biological activity. After adjusting the pH of the sample to neutral with an alkaline or weakly alkaline neutralizing solution, the effect of sensitive and accurate detection of polysaccharide antigens based on immunological methods is achieved;
[0045] (2) The acidic dissociation solution of the present invention has a good dissociation effect. The antigen-antibody complex is dissociated after the sample is treated at 37°C for 2 minutes, which significantly shortens the treatment time compared with the prior art. In addition, the conditions are simple, the operation is simple, and it can be completed under conventional experimental conditions, and it is easy to realize automated operation;
[0046] (3) The dissociation agent and dissociation method of the present invention have a wide range of applications, and have broad application prospects in the field of detecting various polysaccharide antigens such as Aspergillus galactomannan, Candida mannan, Cryptococcal capsular polysaccharide and fungal 1,3-β-D glucan. DETAILED DESCRIPTION
[0047] To further illustrate the technical means and effects of the present invention, the present invention is further described below in conjunction with the embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention, rather than to limit the present invention.
[0048] If no specific techniques or conditions are specified in the examples, the techniques or conditions described in the literature in the field or the product instructions are used. If no manufacturer is specified for the reagents or instruments used, they are all conventional products that can be purchased through regular channels.
[0049] Example 1 Effect of the formula of the acidic dissociation solution on the test results
[0050] In this example, glycine-hydrochloric acid solution and alanine-nitric acid solution of different concentrations were prepared to treat serum samples, and the effects of the formulations of the acidic dissociation solutions on the immunological detection results of Aspergillus galactomannan antigen were analyzed.
[0051] As shown in Table 1, the acidic dissociation solutions prepared with glycine concentration of 0.1-2M, hydrochloric acid concentration of 0.1-5M, or alanine concentration of 0.1-2M, and nitric acid concentration of 0.1-5M all have dissociation effects, among which 0.1M glycine-1M hydrochloric acid solution has the best dissociation effect. The treated samples were used to detect Aspergillus galactomannan antigen, and the test results (Aspergillus galactomannan antigen detection I value, I≥0.5 is positive) were consistent with the test results of the traditional EDTA method.
[0052] Table 1
[0053]
[0054]
[0055] Example 2 Effect of pH of acidic dissociation solution on test results
[0056] In this example, a combination of glycine and hydrochloric acid was used to prepare acidic dissociation solutions with different pH values, serum samples were processed, and the effect of the pH value of the acidic dissociation solution on the immunological detection results of Aspergillus galactomannan antigen was analyzed.
[0057] As shown in Table 2, the I value of Aspergillus galactomannan antigen detection (I ≥ 0.5 is positive), the acidic dissociation solution under the condition of pH -1.0 to 3.0, especially under the condition of pH 0, makes the antigen-antibody complex dissociate rapidly and inactivate the antibody quickly, reducing the influence of the antibody on the immunological detection result of Aspergillus galactomannan antigen. The treated samples are used to detect Aspergillus galactomannan antigen, and the test results obtained are consistent with the test results of the traditional EDTA method.
[0058] Table 2
[0059]
[0060]
[0061] This example further detected the effect of the pH of the acidic dissociation solution on the activity of the antibody. Table 3 shows the detection value of Aspergillus galactomannan IgG (activity ≥120 AU / mL is positive). After the sample was treated with an acidic dissociation solution with a pH of -1.0 to 3.0, the detection result of the antibody in the sample was low, indicating that the antibody was basically inactivated.
[0062] Table 3
[0063]
[0064]
[0065] Example 3 Effect of dissociation conditions on test results
[0066] (1) Volume ratio of acidic dissociation solution to serum sample
[0067] Different volumes of acidic dissociation solution (0.1 M glycine-1 M hydrochloric acid solution, pH=0) were added to the serum samples, and the effect of the volume ratio of acidic dissociation solution to serum samples on the immunological detection results of Aspergillus galactomannan antigen was analyzed.
[0068] As shown in Table 4, the I value of Aspergillus galactomannan antigen detection (I≥0.5 is positive). Under the conditions of the volume ratio of acidic dissociation solution to serum sample being 5:1, 2:1, 1:1, 1:3 and 1:10, especially under the condition of volume ratio being 1:3, the acidic dissociation solution can rapidly dissociate the antigen-antibody complex in the serum sample. The treated samples are used to detect Aspergillus galactomannan antigen, and the obtained test results are consistent with those of the traditional EDTA method.
[0069] Table 4
[0070]
[0071]
[0072] (2) Dissociation temperature
[0073] As shown in Table 5, the I value of Aspergillus galactomannan antigen detection (I ≥ 0.5 is positive), the sample was added with acidic dissociation solution (0.1M glycine-1M hydrochloric acid solution, pH = 0) at a volume ratio of 1:3 and incubated for a period of time at 2-40°C (2-8°C, 16±8°C, 25±5°C, 35±5°C), especially at 37°C. The acidic dissociation solution can rapidly dissociate the antigen-antibody complex in the serum sample. The treated sample was used to detect Aspergillus galactomannan antigen, and the test results obtained were consistent with those of the traditional EDTA method.
[0074] Table 5
[0075]
[0076]
[0077] (3) Dissociation time
[0078] Dissociation was performed at 37°C for 2 to 20 minutes. The I value of Aspergillus galactomannan antigen detection (I ≥ 0.5 was positive) was shown in Table 6. It was found that the antigen-antibody complex could be rapidly dissociated at 37°C for 2 minutes. The treated samples were used to detect Aspergillus galactomannan antigen, and the test results were consistent with those of the traditional EDTA method.
[0079] Table 6
[0080]
[0081] Example 4 Effect of the formula and pH value of the neutralization solution on the test results
[0082] In this example, neutralization solutions with different formulas and different pH values were prepared to analyze the effects of the neutralization solutions on the immunological detection results of Aspergillus galactomannan antigen.
[0083] Table 7 shows the I value of Aspergillus galactomannan antigen detection (I ≥ 0.5 is positive). Different neutralizing solutions can play a neutralizing role in the pH range of 7.0 to 15.0.
[0084] Table 7
[0085]
[0086] Example 5 Effect of Neutralization Conditions on Test Results
[0087] After adding the neutralizing solution to the sample treated with the acidic dissociation solution, a vortex method was used for mixing in order to quickly neutralize the acidic dissociation solution and avoid the influence of the neutralizing solution on the polysaccharide antigens to prevent the neutralizing solution from sinking to the bottom of the sample. The optimal rotation speed of the vortex was 50-400 rpm, and the optimal time was 5-600s. The results had good repeatability (CV<10%), as shown in Table 8.
[0088] Table 8
[0089]
[0090] Example 6 Automated Detection
[0091] In this example, the optimal conditions determined in Examples 1 to 5 were used to process the samples using automated equipment and to perform Aspergillus galactomannan antigen detection, and the steps were as follows:
[0092] (1) Acidic dissociation solution (0.1 M glycine-1 M hydrochloric acid solution, pH = 0) was added to the serum sample at a volume ratio of 1:3 and incubated at 37°C for 2 min to dissociate the antigen-antibody complex;
[0093] (2) Add 1.5 M potassium phosphate solution to the dissociated sample at a volume ratio of 1:4, vortex mix at 200 rpm for 120 s, adjust the sample to a neutral pH, and detect the Aspergillus galactomannan antigen in the sample using an immunoassay kit.
[0094] Table 9 shows the I value of Aspergillus galactomannan antigen detection (I≥0.5 is positive), and the method can be automated.
[0095] Table 9
[0096] Serum samples Manual Operation Automated equipment operation N1 0.12 0.12 N2 0.15 0.15 N3 0.22 0.22 N4 0.15 0.14 N5 0.18 0.18 P1 0.79 0.82 P2 1.59 1.41 P3 2.07 2.09 P4 2.61 2.60 P5 3.14 3.28
[0097] This example further utilizes the above method to process samples containing different polysaccharide antigens, and analyzes the effects of the acidic dissociation solution and neutralization solution on other sugar and its derivative antigens.
[0098] As shown in Table 10, the acidic dissociation solution and neutralization solution can ensure the biological stability of various polysaccharide antigens, including Aspergillus galactomannan, Candida mannan, Cryptococcal capsular polysaccharide and fungal 1,3-β-D glucan.
[0099] Table 10
[0100]
[0101]
[0102] In summary, the acidic dissociation solution and the neutralization solution of the present invention cooperate with each other to achieve the effect of rapid dissociation of polysaccharide antigen-antibody complexes, with short processing time, simple operation, and easy automation, and have broad application prospects in the field of various polysaccharide antigen detection.
[0103] The applicant declares that the present invention illustrates the detailed method of the present invention through the above-mentioned embodiments, but the present invention is not limited to the above-mentioned detailed method, that is, it does not mean that the present invention must rely on the above-mentioned detailed method to be implemented. Those skilled in the art should understand that any improvement of the present invention, equivalent replacement of various raw materials of the product of the present invention, addition of auxiliary components, selection of specific methods, etc., all fall within the protection scope and disclosure scope of the present invention.
Claims
1. A method for dissociating a polysaccharide antigen-antibody complex, characterized in that: The polysaccharide antigens include any one or a combination of at least two of Aspergillus galactomannan, Candida mannan, Cryptococcal capsular polysaccharide or fungal 1,3-β-D glucan; The method uses a polysaccharide antigen-antibody complex dissociating agent to treat the sample; the method comprises the following steps: (1) adding an acidic dissociation solution with a pH of -1.0 to 0 to a sample containing a polysaccharide antigen-antibody complex, wherein the volume ratio of the acidic dissociation solution to the sample is 1:(2 to 4), and incubating at 30 to 40° C. for 2 to 20 min to perform incubation dissociation; (2) Add neutralizing solution with a pH of 7.0-15.0 to the dissociated sample and vortex mix at 50-400 rpm for 5-600 s to adjust the sample containing the polysaccharide antigen-antibody complex to a neutral pH; The acidic dissociation solution is composed of glycine and hydrochloric acid; the concentration of glycine in the acidic dissociation solution is 0.1-2 M; the concentration of hydrochloric acid in the acidic dissociation solution is 0.5-5 M; The neutralizing solution is a potassium phosphate solution with a concentration of 0.1 to 5 M; The volume ratio of the neutralization solution to the sample is 1:(0.2-10).
2. The method for dissociating polysaccharide antigen-antibody complex according to claim 1, characterized in that: The sample in step (1) includes a blood sample.
Citation Information
Patent Citations
Antigen antibody complex dissociation liquid kit and application thereof
CN101832999A
Production and application for schistosoma japonica piezoelectric quality immune sensor
CN1811444A
CIC (circulating immune complex) antigen buffer solution dissociation agent for immune complex buffer dissociation agent
CN103776999A
Immune complex buffer dissociation agent and application thereof
CN103777006A
Immunochromatographic device for extracting and measuring carbohydrate antigens
CN110418963A
